Medicine supply notification: discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices
This product is being discontinued; stock will be exhausted by w/c 18 December 2023. A supply update of other GLP-1 receptor agonists and clinical guidance on alternative treatment options is available from the medicines supply tool on the specialist pharmacy service website.
Source:
Community Pharmacy England
SPS commentary:
Information in the national patient safety alert on the shortage of GLP-1 receptor agonists issued on the 18th July 2023 can be used to guide management of patients switching from lixisenatide.